Before the Trial Begins Flashcards
Outline what is meant by a pre-clinical stage trial
During the pre-clinical stage of drug development, the formulation and manufacturing technique for the product are developed.
Outline what is meant by a Phase I Trial
Phase I studies relate to the safety of the drug under investigation usually in healthy volunteers. They involve the initial introduction of an investigational new drug into humans. The aim is to assess major safety issues and understand how the drug is dealt with in the body.
Outline what is meant by a Phase II Trial
Phase II studies are early controlled clinical studies conducted to obtain some preliminary data on the effectiveness of the drug for a particular indication or indications in patients with the disease or condition. This phase of testing also helps determine the common short-term side effects and risks associated with the drug. These trials are also used to establish which therapies have the potential to be investigated in full-scale, phase III randomised trials while further assessing the safety of these therapies.
Phase II studies are sometimes divided into Phase IIA and Phase IIB. There is no formal definition for these two sub-categories, but generally:
Phase IIA studies are usually pilot studies designed to demonstrate clinical efficacy or biological activity (‘proof of concept’ studies)
Phase IIB studies look to find the optimum dose at which the drug shows biological activity with minimal side-effects (‘definitive dose-finding’ studies). The aim of Phase 11B studies is usually to determine the dose(s) and regimen for Phase III trials.
Outline what is meant by a Phase III Trial
Phase III trials are full-scale randomised controlled trials evaluating the benefits and safety of a drug against a placebo or standard therapy in a substantial number of patients. This is the key stage in establishing the impact of a drug and the majority of drug trials you have come across in this course relate to this type of trial.
Clinical trial in patients with the disease/condition for which the drug under investigation will be registered. To confirm the drug has a therapeutic effect and to determine the optimal dose range and correct frequency of dosing.
Outline what is meant by a Phase IV Trial
Phase IV studies relate to the stage after a drug has been approved and involves the long-term monitoring of the safety of the drug.
List some advantages of conducting a multicentre trial?
Faster recruitment
Greater diversity of patients and more generalisable results
Capacity building in various centres
Setting up collaborations and teams which may be able to work on further trials in the future
List some disadvantages of conducting a multicentre trial?
Variable infrastructure between centres
Different availability of trained personnel
Much greater co-ordination to:
- Standardise equipment and procedures
- Randomise patients
- Translate participant and staff materials
Different recruitment rates between centres
Greater resources required for quality control, assurance and monitoring
List some qualities of a good principle investigator
Scutiny Operational plan Target acheivement Monitoring Concept clearance Record keeping Technical quality COmmunication Rapport Decision making Manpower Mx Sincerity and honesty Hardworking Ownership Approach
What is a Gantt Chart?
A Gantt chart is a graphical representation of the duration of tasks against the progression of time (also known as a timeline).
Why is it important to set up a trial management plan?
Ensures common goals and clear understanding (the plan will be required by agencies that review the proposal for approval)
Facilitates anticipation and identification of any issues
It facilitates a good estimate of the staff and other resources needed and the setting up of the trial budget (the funder will require it)
It facilitates clear evaluation of the study process
List some of the things that might be useful to include on a trial budget
Direct costs (staff and non-staff e.g. equipment, drugs and tests)
Overheads
List some reasons to register a trial
- It is a regulatory requirement
- In order to let collaborators know you are open to adding new sites and for participants to join
- Compiling evidence
- Reducing publication bias and assessing quality of conduct and reporting
- TO avoid duplication of work
- To help investigators focus on unanswered questions and identify gaps in information
- Credibility
What agencies may you need to submit your trial protocol to obtain approval?
Regulatory agencies
Ethical and governance committees at trial sites
Scientific approval from local or national councils
Informal approval from local communities e.g. religious or political
Approval from health ministries or health services
Insurance
Licence of importation or exportation
What considerations need to be taken into account when constructing a risk assessment?
Systematic review evidence Experience from previous projects Involve stakeholders Brainstorming with project team Scenario analysis Reviewing the proposed process looking for weakness
For each risk identified in the assessment what information is worth exploring?
The nature of the risk and the exposure to the risk including probability of ooccurence THe proposed counter-measures WHo is responsible How risks will be monitored Risk triggers